3OB

3-chloro-5-({6-[2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethyl]-3-(dimethylamino)-2-oxo-1,2-dihydropyridin-4-yl}oxy)benzonitrile

Created:	2008-12-08
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where 3OB is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	56
Chiral Atom Count	0
Bond Count	59
Aromatic Bond Count	12

2D diagram of 3OB

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3-chloro-5-({6-[2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethyl]-3-(dimethylamino)-2-oxo-1,2-dihydropyridin-4-yl}oxy)benzonitrile
Systematic Name (OpenEye OEToolkits)	3-chloro-5-[[6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxo-ethyl]-3-dimethylamino-2-oxo-1H-pyridin-4-yl]oxy]benzonitrile
Formula	C₂₅ H₂₃ Cl N₄ O₃
Molecular Weight	462.928
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C2C(N(C)C)=C(Oc1cc(C#N)cc(Cl)c1)C=C(N2)CC(=O)N4Cc3ccccc3CC4
SMILES	CACTVS	3.341	CN(C)C1=C(Oc2cc(Cl)cc(c2)C#N)C=C(CC(=O)N3CCc4ccccc4C3)NC1=O
SMILES	OpenEye OEToolkits	1.5.0	CN(C)C1=C(C=C(NC1=O)CC(=O)N2CCc3ccccc3C2)Oc4cc(cc(c4)Cl)C#N
Canonical SMILES	CACTVS	3.341	CN(C)C1=C(Oc2cc(Cl)cc(c2)C#N)C=C(CC(=O)N3CCc4ccccc4C3)NC1=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	CN(C)C1=C(C=C(NC1=O)CC(=O)N2CCc3ccccc3C2)Oc4cc(cc(c4)Cl)C#N
InChI	InChI	1.03	InChI=1S/C25H23ClN4O3/c1-29(2)24-22(33-21-10-16(14-27)9-19(26)11-21)12-20(28-25(24)32)13-23(31)30-8-7-17-5-3-4-6-18(17)15-30/h3-6,9-12H,7-8,13,15H2,1-2H3,(H,28,32)
InChIKey	InChI	1.03	CLCCLHPVIUSCJF-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	44483200
ChEMBL	CHEMBL1230172

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.